CN1471926A - Injection for enhancing immunity and its preparing method - Google Patents
Injection for enhancing immunity and its preparing method Download PDFInfo
- Publication number
- CN1471926A CN1471926A CNA031354157A CN03135415A CN1471926A CN 1471926 A CN1471926 A CN 1471926A CN A031354157 A CNA031354157 A CN A031354157A CN 03135415 A CN03135415 A CN 03135415A CN 1471926 A CN1471926 A CN 1471926A
- Authority
- CN
- China
- Prior art keywords
- injection
- sulfate
- enhanced
- active immunity
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An injection for improving active immunity is a trace element one prepared from water-soluble compounds including sodium selenite, cobalt sulfate, copper sulfate, zinc gluconate, iron citrate, manganese sulfate, magnesium sulfate, sodium chromate, and sodium vanadate. Its advantages are low dosage and no toxic by-effect.
Description
Technical field
The present invention relates to enhanced injection of a kind of active immunity and preparation method thereof, specifically, relate to Rare Elements Preparations that is used for the human injection and preparation method thereof, belong to medical technical field.
Background technology
Trace element (life unit) and health have physiology and pathology important closely related, are constant at the tissue intensive amount, can not synthesize in the body.Known essential trace element has 14 kinds, they derive from the Nature, water, food, air, since regional soil content difference, the influence of rainfall, difference is very big, people hang up one's hat in a certain place in addition, and main food is produced other area by this ground, call in few, antagonism between the trace element in addition, the antagonism of calcium, the antagonism of element, the oxidoreduction in digestive tract, phytic acid, oxalic acid, the interference of cellulose etc. all influences trace elements absorbed and utilization, and it is extremely low that the selection of intestinal mucosa is absorbed as the oral utilization rate of zinc, when the saturation of ferrum in intestinal mucosa is high, also do not absorb, magnesium ion does not also absorb greatly, is to cause to lack and insufficient main cause.All can cause dysequilibrium, cause physiological imbalance, corresponding pathology and muscular dystrophy occur.Trace element and cellular metabolism, network metabolism have confidential relation, and the cellular metabolism network is by the catalytic reaction system of up to ten thousand kinds of enzymes.Be the film transmission system, signaling system, they interact, and transform mutually, and mutual restriction forms complete, unified, the sensitive system of a cover.Trace element can promote and strengthen the cellular network metabolism, can make disease return to physiological status by pathology, or makes the optimum reverse of physiological function decay, normal physiological function is further strengthened, thereby reach health level.
Studies show that trace element has high biological activity and catalysis biochemical reaction, when human body must trace element and aminoacid, protein or other organic unity close, form various enzymes, hormone, vitamin, be ferrum, copper, zinc, manganese and selenic hundreds of enzyme, contain cobaltic vitamin B12, ferruginous cytochrome oxidases etc. can make the metal organic double compound produce various biological actions, the biochemical reaction of special physiological function and height.
The thyroxine that enzyme that trace elements iron, copper, zinc, manganese, cobalt form and iodine form all can promote the effect of growth promoter.
Trace element is significant to stingy neural structure and physiological function in keeping, can influence the function of endocrine gland, the activity of target cell and the biological agent of hormone, must trace element no mistake in treatment many (ferrum, copper, zinc) or very few (copper zinc) can cause that also endocrine function is not normal, the normal contents of trace element, very important to the function of keeping hypothalamus-brain stem-hypophysis-target cell.
Trace element occupies critical positions in immunologic process, under the adjusting of endocrine-hormone-leukocyte, interior originality material materials such as (LEM), by the nutrition immune effect, form complete homeostasis, to bring into play maximum immunity and to engulf function and defeat infection, subdue or suppress the harmful microbe pathogenic effects.
Factors such as geromorphism removes and heredity, and nucleic acid is rotten are relevant, lack trace element with human body, cause microcirculation disturbance relevant, and human body will lean on blood flow transportation nutrition, removes refuse.If capillary tube circulation is not smooth, nutrition exchange and refuse are got rid of and will be affected between tissue, light dysfunction then, and heavy then organ degeneration, necrosis loses function, causes the unified body of coordinating aging to occur.
At present, the medicine that improves self active immunity power is more, product with the necessary nutrient of oral supplementation human body is more, such as Gold Theragran (executing expensive precious pharmaceutcal corporation, Ltd, the production of Hangzhou Pharmaceutical Group Co.,Ltd) by Jinan vitality Science and Technology Ltd., Shanghai, claim multivitamin and minerals tablet again, be a kind of nutritional supplementation oral medicine, but absorb slow, and every day, dose was big, and weak effect can not comprehensively work because of being subjected to various interference and antagonism.In addition, patent of invention has been number for CN02113663.7 discloses a kind of Rare Elements Preparations and preparation method that is used for poultry owing to use injection for poultry, at object simple, act on single.
Summary of the invention
Purpose of the present invention just provides a kind of people's of being used for the enhanced injection of active immunity, specifically, just provides a kind of human injection's of being used for Rare Elements Preparations.
Another object of the present invention provides the preparation method of the enhanced injection of this active immunity.
The invention provides the enhanced injection of a kind of active immunity, it is to be that feedstock production forms by water soluble compound, and the percentage by weight of each component raw material is:
Sodium selenite 0.01～0.02%, cobaltous sulfate 0.04～0.06%, copper sulfate 0.1～0.4%, zinc gluconate 0.6～1.0%, ferric citrate 0.5～1.0%, manganese sulfate 0.05～0.08%, magnesium sulfate 0.01～0.03%, sodium chromate 0.01～0.2%, vanadic acid sodium 0.0005～0.0010%, surplus are water for injection.
Further, the percentage by weight of said each component raw material of water soluble compound is:
Sodium selenite 0.02%, cobaltous sulfate 0.06%, copper sulfate 0.1%, zinc gluconate 1.0%, ferric citrate 1.0%, manganese sulfate 0.05%, magnesium sulfate 0.03%, sodium chromate 0.01%, vanadic acid sodium 0.0005%, surplus are water for injection.
The present invention also provides the preparation method of the enhanced injection of this active immunity, and concrete steps are:
A, take by weighing raw material by required weight;
B, in step a, add injection water 50～60ml, heated and stirred, fully dissolving, cooling adds 2% benzyl alcohol, adds the injection water again to 100ml, filter, packing, sterilization is promptly.
The enhanced injection of above-mentioned said active immunity is the human body intramuscular dose, and wherein injecting accumulated dose is 2～8ml, divides 2～3 injections.
The pH value of this human muscle's injection is 2.5～4, and pH value is too high, and trace element can produce precipitation and separate out, owing to added benzyl alcohol, can reduce the low pain that causes of PH.
Among the present invention, increasing selenic content, is relevant with the health of cardiovascular and cerebrovascular vessel because of selenium, and it can protect the capillary vascular health, prevents that permeability from oozing out the generation of the exudative diathesis disease of formation.
Medicine of the present invention has significant effect aspect raising human body self active immunity power.Medicine of the present invention is a Rare Elements Preparations, by a supply human body and various enzyme are activated, increase the cellular network metabolism, make the cellular-restoring health of human body, each organ, reach coordination operation, and consumption is little, frequency injection is few, easy to use, provide a kind of new microelement complement mode for clinical, providing a kind of new selection aspect the immunity of human body itself improving.
Obviously, according to foregoing of the present invention,,, can also make modification, replacement or the change of other various ways not breaking away under the above-mentioned basic fundamental thought of the present invention prerequisite according to the ordinary skill knowledge and the customary means of this area.
The specific embodiment of form is described in further detail foregoing of the present invention again by the following examples.But this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following example.All technology that realizes based on foregoing of the present invention all belong to scope of the present invention.
The specific embodiment
Below prove the beneficial effect of medicine of the present invention by pharmacodynamic experiment, clinical trial.
Experimental example 1 medicine effect of the present invention is learned test
The present invention has done a large amount of experiments rabbit, dog, cat, pig, cattle, sheep.
Mix poisoning by kind of sheep because of adopting Rogor and decis, cause gastrointestinal hemorrhage regulating liver-QI, nephrotoxicity degeneration 30 examples, light disease 15 examples, serious symptom 15 examples, through antidotal therapy, light disease is taken a turn for the better, and serious symptom is dead 12 examples in January.Cut open the inspection symptom, hydrosarca muscle is pale, and hepatomegaly fat becomes, matter is crisp easily mashed, 3 routine serious symptom sheep injections medicine 12ml of the present invention begins to occur appetite after 3 days, recover normal after April, blood examination erythrocyte 1,500,000 to 1100 about ten thousand, cut open extremely two and see that liver fat becomes and disappear, become aubergine by yellow, size, it is normal that quality is recovered, and illustrates that medicine of the present invention has the effect of repairing impaired organ.
And drug use safety of the present invention, domestic animal is strong, and is few sick, and per 0.5 kilogram of piglet or lamb, rabbit injection 2ml/ are better every 10 days filling primary effects.The clinical trial of experimental example 2 medicines of the present invention
1, the clinical trial of medicine of the present invention lung large-area fibreization that human immune deficiency is caused
By lung large-area fibre clinical case 1 example that human immune deficiency is caused, through hormone therapy 1 year, clinical symptoms alleviated a little, but weak, hypoimmunity is by intramuscular injection total amount 8ml (dividing 3 times), sb.'s illness took a favorable turn, and pulmonary fibrosis disappears 70% after 5 months, injects and do not have flu later six months.
2, medicine of the present invention is to the clinical trial of cancer patient and patients after surgery
By to cancer patient and postoperative patient totally 2 examples, especially digestive tract recovers extreme difference, and the amount of having a meal is few, and flatulence is not relaxed and diarrhoea after meal, weight loss, and intramuscular injection 8ml (at twice), appetite increases, flatulence and diarrhoea, few flu, body constitution increases.
3, medicine of the present invention is hemorrhage to cerebrovascular sclerosis, renal anemia, erythrocyte aplastic anemia, gastritis, the clinical trial of diseases such as cholecystitis
By hemorrhage to cerebrovascular sclerosis, renal anemia, the erythrocyte aplastic anemia, gastritis, analysiss of cases such as cholecystitis, intramuscular injection totally 4～8ml in 6～9 months divides 2～3 injections respectively, and body constitution strengthens, through injecting 2ml for the first time, after the week, clinical symptom relief; Medicine of the present invention of every injection, clinical card shape all before have and alleviate or disappear, and the effect that improves gastrointestinal function are arranged, effective percentage 90%.
4, medicine of the present invention is to the clinical trial of diabetes
By the analysis of cases to 14 routine diabetes patients, the body constitution of generally becoming thin is recovered, and energy is good, and blood sugar recovery is normal, weight increase, effective percentage 100%.
5, medicine of the present invention is to weak and sickly, the clinical trial of infantile anorexia and dysplasia
Medicine of the present invention is primarily aimed at weak and sickly.The digestive functional disturbance face does not have color, the no good result of taking medicine for a long time, and body constitution strengthens after intramuscular injection, has rosy cheeks, and appetite is good, has no interest.Body constitution is recovered to reach more than 95%.
To child's anorexia, 7 examples of dysplasia, intramuscular injection 2～4ml in 6 months respectively, frequency injection 2～3 times, inject medicine of the present invention first, appetite obviously increases, and gastrointestinal function improves, after 6 months, infants ' physique is solid, but does not have the phenomenon of filling out, and increases obviously, and effective percentage reaches 100%.
6, medicine of the present invention is to the clinical trial of coronary heart disease
Early coronary disease core ischemia 3 examples, by injecting medicine of the present invention 3 times, each 1～2ml owing to improve blood supply of cardiac muscle, recovers damaged myocardium, clinical symptom disappearance, physical recovery health reaches 100%.
In sum, medicine of the present invention adopts the human body deep intramuscular injection, and accumulated dose is adult 5～8ml, and child 2～6ml divides 2～3 injections.Do not breaking away under the above-mentioned basic fundamental thought of the present invention prerequisite, can also make modification, replacement or the change of other various ways, can increase to 15～20ml for the critical illness people, divide 3～5 injections, it is slow that injection speed is wanted, gently rub injection after the injection, also can hot compress at once alleviate distending pain in the injection site to quicken diffusion.
The clinical use of this product has no side effect, and produce effects appears at after the per injection one thoughtful about one month, and 3～May is best, also is the disappearance phase of clinical symptoms, and body constitution was recovered sustainable about 1 year, if body constitution does not descend, need not inject.
Prove that by above clinical trial medicine of the present invention is for strengthening human body active immunity power, injected dose is little, and frequency injection is few, and clinical effectiveness is good, and is safe in utilization, no toxicity.
Experimental example 3 toxicity tests
Medicine of the present invention passes through 1,000,000 domestic animals (about 1 jin of newborn animal), and intramuscular injection safety has no side effect, and people's 60 examples (wherein aged and adult's 53 examples, child's 7 examples) all safety have no adverse reaction.
By above-mentioned pharmacological testing and clinical trial are proved, medicine of the present invention can strengthen human body active immunity power, and effect is better, have no side effect, and do not need long-term prescription, frequency injection is few, easy to use, be not to be conspicuous, be a kind of new mode that strengthens the human body active immunity.
The detection method of experimental example 4 trace element
1, copper: precision is measured this product 1ml, put in the 100ml volumetric flask, add hydrochloric acid solution (1 → 100) and be diluted to scale, shake up, (" 2000 editions each methods of appendix VD. of Chinese pharmacopoeia are injected atomic spectrophotometer, measure absorbance at 324.8nm wavelength place according to the atom spectrophotography, according to the content of the copper of standard curve calculation sample, its scope is at 400ug/ml～1600ug/ml.
2, ferrum: precision is measured this product 1ml, put in the 200ml volumetric flask, add hydrochloric acid solution (1 → 100) and be diluted to scale, shake up, (" 2000 editions each methods of appendix VD. of Chinese pharmacopoeia are injected atomic spectrophotometer, measure absorbance at 248.3nm wavelength place according to the atom spectrophotography, according to the content of the ferrum of standard curve calculation sample, its scope is at 1 143ug/ml～2286ug/ml.
3, zinc: precision is measured this product 1ml, put in the 100ml volumetric flask, add hydrochloric acid solution (1 → 100) and be diluted to scale, shake up, (" 2000 editions each methods of appendix VD. of Chinese pharmacopoeia are injected atomic spectrophotometer, measure absorbance at 213.9nm wavelength place according to the atom spectrophotography, according to the content of the zinc of standard curve calculation sample, its scope is at 855ug/ml～1425ug/ml.
4, cobalt: precision is measured this product 1ml, put in the 50ml volumetric flask, add hydrochloric acid solution (1 → 100) and be diluted to scale, shake up, (" 2000 editions each methods of appendix VD. of Chinese pharmacopoeia are injected atomic spectrophotometer, measure absorbance at 250.7nm wavelength place according to the atom spectrophotography, according to the cobaltic content of standard curve calculation sample, its scope is at 152ug/ml～228ug/ml.
Adopt spectrophotography, under different wavelength, can measure the scope of other element.
Below be the preparation method of medicine of the present invention, but be not limitation of the present invention.
Embodiment 1
Get sodium selenite 20g, cobaltous sulfate 60g, copper sulfate 200.0g, zinc gluconate 1000g, ferric citrate 1000g, manganese sulfate 50g, magnesium sulfate 30g, sodium chromate 10g, vanadic acid sodium 1g, benzyl alcohol 200ml adds injection water 30%--40% earlier, heated and boiled, abundant stirring and dissolving, after the cooling, add benzyl alcohol, add injection water to 10 ten thousand ml again, filtration is sub-packed in molten envelope in the 2ml ampoule, sterilization, lamp inspection, safe biologic test, packing.
Embodiment 2
Get sodium selenite 10g, cobaltous sulfate 40g, copper sulfate 100.0g, zinc gluconate 600g, ferric citrate 500g, manganese sulfate 60g, magnesium sulfate 15g, sodium chromate 15g, vanadic acid sodium 0.5g, benzyl alcohol 200ml, compound method is with embodiment 1.
Embodiment 3
Get sodium selenite 15g, cobaltous sulfate 50g, copper sulfate 400.0g, zinc gluconate 800g, ferric citrate 700g, manganese sulfate 70g, magnesium sulfate 20g, sodium chromate 15g, vanadic acid sodium 0.7g, benzyl alcohol 200ml, compound method is with embodiment 1.
Claims (6)
1, the enhanced injection of a kind of active immunity is characterized in that it is is that feedstock production forms by water soluble compound, and the percentage by weight of each component raw material is:
Sodium selenite 0.01～0.02%, cobaltous sulfate 0.04～0.06%, copper sulfate 0.1～0.4%, zinc gluconate 0.6～1.0%, ferric citrate 0.5～1.0%, manganese sulfate 0.05～0.08%, magnesium sulfate 0.01～0.03%, sodium chromate 0.01～0.2%, vanadic acid sodium 0.0005～0.0010%, surplus are water for injection.
2, the enhanced injection of active immunity according to claim 1 is characterized in that the percentage by weight of said each component raw material of water soluble compound is:
Sodium selenite 0.02%, cobaltous sulfate 0.06%, copper sulfate 0.1%, zinc gluconate 1.0%, ferric citrate 1.0%, manganese sulfate 0.05%, magnesium sulfate 0.03%, sodium chromate 0.01%, vanadic acid sodium 0.0005%, surplus are water for injection.
3, the preparation method of the enhanced injection of the described active immunity of claim 1 is characterized in that it is by following steps:
A, take by weighing raw material by required weight;
B, in step a, add injection water 50～60ml, heated and stirred, fully dissolving, cooling adds 2% benzyl alcohol, adds the injection water again to 100ml, filter, packing, sterilization is promptly.
4, according to claim 1, the enhanced injection of 2 described active immunities is characterized in that this injection is the agent of human body deep intramuscular injection.
5, the enhanced injection of active immunity according to claim 4 is characterized in that the injection accumulated dose of this human body deep intramuscular injection agent is 2～8ml, divides 2～3 injections.
6, the enhanced injection of active immunity according to claim 4, the pH value that it is characterized in that this human muscle's injection is 2.5～4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03135415 CN1203865C (en) | 2003-07-15 | 2003-07-15 | Injection for enhancing immunity and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03135415 CN1203865C (en) | 2003-07-15 | 2003-07-15 | Injection for enhancing immunity and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1471926A true CN1471926A (en) | 2004-02-04 |
| CN1203865C CN1203865C (en) | 2005-06-01 |
Family
ID=34154627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03135415 Expired - Fee Related CN1203865C (en) | 2003-07-15 | 2003-07-15 | Injection for enhancing immunity and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1203865C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103340895A (en) * | 2013-06-27 | 2013-10-09 | 江西博意特科技有限公司 | Composition containing various microelements, preparation and preparation method thereof |
-
2003
- 2003-07-15 CN CN 03135415 patent/CN1203865C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103340895A (en) * | 2013-06-27 | 2013-10-09 | 江西博意特科技有限公司 | Composition containing various microelements, preparation and preparation method thereof |
| CN103340895B (en) * | 2013-06-27 | 2015-02-18 | 江西博意特科技有限公司 | Composition containing various microelements, preparation and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1203865C (en) | 2005-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102077936B (en) | Special sea dietary food for diabetics | |
| CN102077940B (en) | Special dietary marine food for patients with coronary heart disease | |
| CN102077939B (en) | Marine special dietary food special for fat people | |
| CN102077938B (en) | Special marine dietary food for patients with liver deficiency | |
| CN102077934A (en) | Special dietary marine food for patients with high blood pressure | |
| CN100344326C (en) | Iron-supplementing preparation | |
| CN107164446A (en) | The preparation method and its antifatigue effect of deer hemepeptide | |
| CN1535605A (en) | Drink and food | |
| CN105878397A (en) | Composition capable of regulating transportation stress of cattle and sheep | |
| CN1203865C (en) | Injection for enhancing immunity and its preparing method | |
| CN102077943B (en) | Seafood for special dietary uses for hypomnesia patients | |
| CN100344291C (en) | Nutritive lead discharging oral liquid and its preparation method | |
| CN1317033C (en) | Blood nourishing body building composition and its production method | |
| CN111493221A (en) | Traditional Chinese medicine feed additive for improving animal immunity and preparation method thereof | |
| CN1117561C (en) | Compounded calcium preparation, preparing method and use thereof | |
| CN1850270A (en) | Ovotransferrin iron supplement agent, and its preparing method and use | |
| CN105920606A (en) | Compound oral liquid for treating children diarrhea and preparation method thereof | |
| CN102077941B (en) | Special dietary seafood special for climacteric women | |
| CN1820740A (en) | Oral liquor for supplementing calcium and zinc and preparing method | |
| CN1197485C (en) | Sugarless protein nutrient solution and its preparation method | |
| CN1087611C (en) | Oral nutrient lead-expelling powdered granules | |
| CN102309572A (en) | Blood nourishing oral liquid and preparation method thereof | |
| CN1201742C (en) | Hypoglycemic health-care food for diabetes type II; | |
| CN1262270C (en) | Application of levocarnitine and its derivative in preventing and treating high altitude diseases | |
| CN1634069A (en) | Calcium, zinc and ferrum composite oral liquor and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050601 Termination date: 20100715 |